Testing tumor samples to predict chemotherapy response in ovarian cancer

Researchers are developing a test called ChemoINTEL that analyzes your tumor sample to see how it responds to different chemotherapy drugs in the lab. By pairing this lab information with how you actually respond to treatment, the study aims to create a personalized prediction tool that could help your doctor choose the chemotherapy most likely to work for you. This approach would move away from a one-size-fits-all treatment plan toward a plan tailored specifically to your tumor.

Currently, oncologists choose chemotherapy drugs based on general guidelines developed from large studies of many patients—not on how your specific tumor is likely to respond. This study exists to fill that gap by creating a predictive tool that uses your individual tumor's characteristics to guide treatment selection.